Only Kobberø Lauridsen et al. explored the effects of genetic variants of NPC1L1 (–133A>G and V1296V T>C), mimicking treatment with ezetimibe, on breast cancer risk. The gene discussed is NPC1L1; the disease is breast carcinoma.